首页 | 本学科首页   官方微博 | 高级检索  
     


Two cases of cisplatin-induced permanent renal failure following neoadjuvant chemotherapy for esophageal cancer
Affiliation:1. Department of Surgery, Akita University Graduate School of Medicine, Akita, Japan;2. Department of Surgery, Comprehensive Cancer Control, Akita University Graduate School of Medicine, Akita, Japan;3. Department of Hematology, Oncology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan;4. Department of Clinical Oncology, Akita University Graduate School of Medicine, Akita, Japan;5. Radiology, Akita University Graduate School of Medicine, Akita, Japan;6. Gastroenterology, Akita University Graduate School of Medicine, Akita, Japan
Abstract:IntroductionWe experienced two esophageal cancer patients who developed severe acute renal failure after neoadjuvant chemotherapy with cisplatin and 5-fluorourasil.Presentation of caseAfter administration of cisplatin, their serum creatinine increased gradually until they required hemodialysis and their renal failure was permanent. In both cases, renal biopsy examination indicated partial recovery of the proximal tubule, but renal function did not recover. After these events, one patient underwent definitive radiotherapy and the other underwent esophagectomy for their esophageal cancers, while continuing dialysis. Both patients are alive without cancer recurrence.DiscussionIn these two cases of cisplatin-induced renal failure, renal biopsy examination showed only slight disorder of proximal tubules and tendency to recover.ConclusionAlthough cisplatin-related nephrotoxicity is a well-recognized complication, there have been few reports of renal failure requiring hemodialysis in cancer patients. In this report, we present their clinical courses and the pathological findings of cisplatin-related renal failure.
Keywords:Renal failure  Cisplatin  Esophageal cancer  Neoadjuvant chemotherapy
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号